FLUTICASONE Drug Patent Profile

Name: FLUTICASONE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Fluticasone, and what generic alternatives are available?

Fluticasone is a drug marketed by Glenmark Speclt, Cosette, Encube, Fougera Pharms, Nesher Pharms, Padagis Israel, Glenmark Pharms Ltd, Bright, Chartwell Rx, Taro Pharm Inds, Apotex, Aurobindo Pharma Ltd, Hikma, Rubicon, Rubicon Research, Respirent Pharms, and Teva Pharms Usa. and is included in twenty-seven NDAs.

The generic ingredient in FLUTICASONE is fluticasone propionate; salmeterol xinafoate. There are twenty-nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Fluticasone

A generic version of FLUTICASONE was approved as fluticasone propionate; salmeterol xinafoate by HIKMA on December 17^th, 2020.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FLUTICASONE?
What are the global sales for FLUTICASONE?
What is Average Wholesale Price for FLUTICASONE?

Summary for FLUTICASONE

US Patents:	0
Applicants:	17
NDAs:	27
Drug Prices:	Drug price information for FLUTICASONE
Drug Sales Revenues:	Drug sales revenues for FLUTICASONE
DailyMed Link:	FLUTICASONE at DailyMed

Drug patent expirations by year for FLUTICASONE

US Patents and Regulatory Information for FLUTICASONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms Usa	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	213948-003	Dec 13, 2021	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Respirent Pharms	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	214464-001	Jan 12, 2026		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Respirent Pharms	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	214464-002	Jan 12, 2026		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Glenmark Speclt	FLUTICASONE PROPIONATE	fluticasone propionate	AEROSOL, METERED;INHALATION	219602-001	Mar 3, 2026	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Glenmark Pharms Ltd	FLUTICASONE PROPIONATE	fluticasone propionate	SPRAY, METERED;NASAL	218742-001	Mar 16, 2026		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Rubicon Research	FLUTICASONE PROPIONATE	fluticasone propionate	SPRAY, METERED;NASAL	218321-001	Jun 5, 2025	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Glenmark Pharms Ltd	FLUTICASONE PROPIONATE	fluticasone propionate	LOTION;TOPICAL	090759-001	May 2, 2011		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for FLUTICASONE

Does Fluticasone help with nasal congestion?

AI Deep Research

Questions you can ask:

Summary for FLUTICASONE

DrugChatter Q&A for FLUTICASONE

Make Better Decisions: Try a trial or see plans & pricing